Glenmark Pharmaceutical has entered into an exclusive arrangement with Immanence-IDC, a leading Canadian company for the distribution of their high-end anti-aging cosmeceutical range of products. The agreement will span across eight operating countries viz., India, Brazil, Mexico, South Africa, Egypt, Vietnam, Malaysia and Thailand. This will mark Glenmark's presence in this fast growing specialised dermatology segment which is growing at a rapid pace across emerging economies.

Arvind Vasudeva, COO, Glenmark, said, “This association marks a new beginning for us in one of the fastest growing segments in dermatology. With emerging economies registering good economic growth in the past decade, this niche segment has been witnessing a transformation and there is a significant need for these high-end products across our operating countries. The IDC cosmeceutical range of products are based on a solid scientific foundation and have been successfully launched in few countries. This association will enable us consolidate our leadership position in dermatology across operating branded generic markets.”

Dr Eric Dupont, chairman of the Board at Immanence-IDC, said, “This ten-year agreement with Glenmark will open new markets for us and through a network of more than 1.50 dermatologists, will allow us to reach more than 1.5 billion people. We are honoured that a global leader in dermatology has recognized the science and quality behind our anti-age care products, as well as our innovative approach.”

“The IDC line is already available in Canada and in France, and is sold in pharmacies and para-pharmacies (OTC pharmacies) that offer consultation services. With this strategic union, IDC will be available in over 12 countries, and he product range will be marketed to dermatologists and pharmacies. Our goal is to establish a presence in over 25 countries over the next two years.” affirmed Luc Dupont, president and CEO at Immanence-IDC.